We suggest that two drugs available for human use, sulforaphane, which increases glutathione, and pyroglutamate, which is converted to glutamate in the glutathione cycle, may be therapeutically beneficial
composition when the composition is in the form of a lyophilizate, it is preferred that the viscosity, the tonicity of and the component concentrations in the aqueous solution derived therefrom is within the respective ranges mentioned hereinbefore
It's gentle yet effective, and I've experienced no side effects
Clinical trial data on IV glutathione in Parkinsons remains limited and mixed, so it is prescribed as an adjunct within a broader treatment plan rather than a standalone therapy
Health Canada classifies them accordingly, and suppliers operating within Canadian guidelines provide them for non-therapeutic research use
For a 70 kg person, this is ~0.11 mg/kg/day